European Modular Education and Training Programme in Safety Sciences for Medicines

European Modular Education and Training Programme in Safety Sciences for Medicines

Training the next generation of Safety Scientists in Europe.

Funding: The project is receiving support from the Innovative Medicines Initiative Joint Undertaking, resources of which are composed of financial contribution from the EU's 7th Framework Programme and EFPIA companies.

Timeline: 2012-2017

Description: SafeSciMET has established a new and unique pan-European education and training network, providing master’s level courses in safety sciences for medicines. The training has focus on holistic, integrative and translational approaches.

Biopeople's role:
Couse Director. Biopeople / University of Copenhagen is involved in the training course concerning regulatory aspects of safety sciences.

Project Partners:

  • VU University Amsterdam
  • University of Konstanz
  • University of Surrey
  • EUFEPS
  • Uppsala University
  • University of Copenhagen
  • Universiteit Leiden
  • Universite de Lorraine
  • Martin-Luther-University
  • HalleKarolinska Institutet Stockholm
  • University of Vienna
  • Universite de Paris-Sud
  • MRC Centre for Drug Safety Science
  • Universidade de Lisboa
  • Charite University Medicine Berlin
  • Almirall
  • AstraZeneca Ltd
  • Bayer-Schering Pharma AG
  • Boehringer-Ingelheim Pharma
  • Eli-Lilly Ltd
  • GlaxoSmithKline Ltd
  • F. Hoffmann-La Roche
  • Lundbeck A/S
  • Merck KGaA
  • Novartis Pharma AG
  • Novo Nordisk A/S
  • Orion Pharma
  • Sanofi
  • UCB Pharma S.A.

External URL

Biopeople is co-funded by the Ministry of Higher Education and Science, Denmark.

Project: European Modular Education and Training Programme in Safety Sciences for Medicines
Close
What are you looking for?
By using this website, you agree to the use of Cookies to give you the best user experience.Ok